Kanamycin sulphate (Kannasyn - Bayer) was introduced in Britain in 1959 mainly for use against resistant staphylococci. More recently the manufacturers have re-assessed the drug, and they now advocate it only for infections caused by Gram-negative organisms.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.